AstraZeneca Aktie
| 161,75EUR | -2,40EUR | -1,46% |
WKN: 886455 / ISIN: GB0009895292
Diese Analysten bewerten die AstraZeneca-Aktie
| Analyst | Buy | Hold | Sell | Kursziel | Abstand | Datum |
|---|---|---|---|---|---|---|
| JP Morgan Chase & Co. | 160,00£ | 14,65% | 23.04.26 | |||
| UBS AG | 176,00£ | 26,11% | 10.04.26 | |||
| Jefferies & Company Inc. | 180,00£ | 28,98% | 10.04.26 | |||
| Barclays Capital | 165,00£ | 18,23% | 31.03.26 | |||
| Deutsche Bank AG | 115,00£ | -17,60% | 30.03.26 | |||
| Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | 170,00£ | 21,81% | 16.03.26 | |||
| Bernstein Research | 205,00£ | 46,89% | 13.02.26 | |||
| Goldman Sachs Group Inc. | 163,89£ | 17,43% | 28.01.26 |
Historische Rating-Entwicklung
|
0
Buy
0
Hold
0
Sell
Aktuell
|
0
Buy
0
Hold
0
Sell
vor 1/2 Jahr
|
0
Buy
0
Hold
0
Sell
vor 1 Jahr
|